CSS
ABVX

Cubist Systematic Strategies’s Abivax ABVX Stock Holding History

Cubist Systematic Strategies’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$773K Buy
+9,107
New +$558K ﹤0.01% 2066
2025
Q2 		– Sell
-10,152
Closed -$63.5K – 2895
2025
Q1 		$63.5K Buy
10,152
+2,595
+34% +$17.6K ﹤0.01% 2688
2024
Q4 		$55.3K Sell
7,557
-8,896
-54% -$81.9K ﹤0.01% 2775
2024
Q3 		$190K Buy
16,453
+10,426
+173% +$125K ﹤0.01% 2585
2024
Q2 		$79.7K Sell
6,027
-7,995
-57% -$114K ﹤0.01% 2658
2024
Q1 		$201K Sell
14,022
-9,278
-40% -$120K ﹤0.01% 3077
2023
Q4 		$249K Buy
+23,300
New +$237K ﹤0.01% 2883

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Cubist Systematic Strategies's ABVX Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Abivax (ABVX) in Q3 2025: 9,107 shares worth $773K. The stake represents ﹤0.01% of the portfolio and ranks #2066 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in ABVX as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in ABVX in Q4 2023 and has held it in 7 quarters since. 165 funds tracked by Wall St. Rank hold ABVX as of Q3 2025.

  • Cubist Systematic Strategies held 9,107 shares of Abivax worth $773K as of Q3 2025.
  • Abivax was a new Cubist Systematic Strategies position in Q3 2025.
  • Abivax made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2066 holding.
  • Cubist Systematic Strategies first reported a position in Abivax in Q4 2023 and has held it in 7 quarters since.
  • 165 funds tracked by Wall St. Rank held Abivax as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.